Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Golimumab plus methotrexate versus methotrexate alone in methotrexate-naive psoriatic arthritis
2013-000643-40Phase 3Completed
- Sponsor
- Instituto de Medicina Molecular João Lobo Antunes
- Start
- Sep 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in psoriatic arthritis (PsA) comparing Golimumab + methotrexate with Methotrexate monotherapy (2 arms). Primary endpoint: Change from baseline in Dactylitis Severity Score. Started Sep 2013; status: completed.
02
Drugs
golimumabmethotrexate
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on 2013-000643-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000643-40.